{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:20:49Z","timestamp":1790734849963,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007460","name":"Arvid Nilsson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004824","name":"Dansk Nefrologisk Selskab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Foundation","doi-asserted-by":"publisher","award":["19-2397"],"award-info":[{"award-number":["19-2397"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","award":["21-B-0387"],"award-info":[{"award-number":["21-B-0387"]}],"id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.rpth.2024.102350","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T01:03:34Z","timestamp":1707959014000},"page":"102350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease"],"prefix":"10.1016","volume":"8","author":[{"given":"Ellen Linnea Freese","family":"Ballegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Bjerring","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102350_bib1","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rpth.2024.102350_bib2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2014.393","article-title":"Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy","volume":"87","author":"Liao","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102350_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rpth.2024.102350_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.112.099606","article-title":"Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States","volume":"126","author":"Goldstein","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102350_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2024.102350_bib6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102350_bib7","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US renal data system 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rpth.2024.102350_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.thromres.2005.03.032","article-title":"Uremic bleeding: pathophysiology and clinical risk factors","volume":"118","author":"Sohal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102350_bib9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102350_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib12","doi-asserted-by":"crossref","first-page":"k342","DOI":"10.1136\/bmj.k342","article-title":"Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care","volume":"360","author":"Kumar","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2024.102350_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000521494","article-title":"Warfarin use, stroke, and bleeding risk among pre-existing atrial fibrillation US veterans transitioning to dialysis","volume":"146","author":"Sy","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.rpth.2024.102350_bib14","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.kint.2016.10.017","article-title":"The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation","volume":"91","author":"Keskar","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102350_bib16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2020.01.019","article-title":"Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and end-stage renal disease","volume":"75","author":"Pokorney","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102350_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102350_bib18","first-page":"33","article-title":"Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin","volume":"2","author":"Lai","year":"2009","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.rpth.2024.102350_bib19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.ajkd.2016.10.018","article-title":"Warfarin initiation, atrial fibrillation, and kidney function: comparative effectiveness and safety of warfarin in older adults with newly diagnosed atrial fibrillation","volume":"69","author":"Jun","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rpth.2024.102350_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfu334","article-title":"Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation","volume":"30","author":"Genovesi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rpth.2024.102350_bib21","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacep.2020.06.036","article-title":"Clinical outcomes of warfarin initiation in advanced chronic kidney disease patients with incident atrial fibrillation","volume":"6","author":"Agarwal","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.rpth.2024.102350_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2015.05.019","article-title":"Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation","volume":"66","author":"Shen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rpth.2024.102350_bib23","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102350_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102350_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2018.05.005","article-title":"Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"94","author":"Wanner","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102350_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.rpth.2024.102350_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.rpth.2024.102350_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CLEP.S245060","article-title":"Existing data sources in clinical epidemiology: laboratory information system databases in Denmark","volume":"12","author":"Arendt","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.rpth.2024.102350_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.rpth.2024.102350_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/14017431.2012.673728","article-title":"Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry","volume":"46","author":"Rix","year":"2012","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.rpth.2024.102350_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2024.102350_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2215\/CJN.10821011","article-title":"Estimating baseline kidney function in hospitalized patients with impaired kidney function","volume":"7","author":"Siew","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1403494809341095","article-title":"The study design and characteristics of the Danish national health interview surveys","volume":"37","author":"Ekholm","year":"2009","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.rpth.2024.102350_bib34","first-page":"1","article-title":"Marginal structural models","author":"Robins","year":"1998","journal-title":"Proc Am Stat Assoc Sect Bayesian Stat Sci"},{"key":"10.1016\/j.rpth.2024.102350_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.rpth.2024.102350_bib40","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102350_bib41","first-page":"2015","article-title":"A\u00a0systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2175","article-title":"Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"3","author":"Randhawa","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2024.102350_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2024.102350_bib44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102350_bib45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102350_bib46","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102350_bib47","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102350_bib48","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102350_bib49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A\u00a0randomized controlled trial comparing apixaban to the vitamin K-antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102350_bib50","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102350_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10557-021-07144-8","article-title":"Effect of rivaroxaban or apixaban in atrial fibrillation patients with stage 4-5 chronic kidney disease or on dialysis","volume":"35","author":"Chen","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.rpth.2024.102350_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033283","article-title":"GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study","volume":"9","author":"Dalgaard","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2024.102350_bib53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102350_bib54","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102350_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/nep.13207","article-title":"Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation","volume":"24","author":"Tan","year":"2019","journal-title":"Nephrology (Carlton)"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:29:11Z","timestamp":1762864151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2475037924000396"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102350","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102350"}}